111 related articles for article (PubMed ID: 2476640)
1. The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia.
Wang C; Curtis JE; Geissler EN; McCulloch EA; Minden MD
Leukemia; 1989 Oct; 3(10):699-702. PubMed ID: 2476640
[TBL] [Abstract][Full Text] [Related]
2. Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.
Wang C; Koistinen P; Yang GS; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Jun; 5(6):493-9. PubMed ID: 1711640
[TBL] [Abstract][Full Text] [Related]
3. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
[TBL] [Abstract][Full Text] [Related]
5. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
6. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
8. c-KIT expression enhances the leukemogenic potential of 32D cells.
Hu Q; Trevisan M; Xu Y; Dong W; Berger SA; Lyman SD; Minden MD
J Clin Invest; 1995 Jun; 95(6):2530-8. PubMed ID: 7539453
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
Ikeda H; Kanakura Y; Tamaki T; Kuriu A; Kitayama H; Ishikawa J; Kanayama Y; Yonezawa T; Tarui S; Griffin JD
Blood; 1991 Dec; 78(11):2962-8. PubMed ID: 1720040
[TBL] [Abstract][Full Text] [Related]
10. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
[TBL] [Abstract][Full Text] [Related]
11. Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines.
Tohda S; Yang GS; Ashman LK; McCulloch EA; Minden MD
J Cell Physiol; 1993 Feb; 154(2):410-8. PubMed ID: 7678840
[TBL] [Abstract][Full Text] [Related]
12. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Carlo-Stella C; Cazzola M; De Fazio P; Pedrazzoli P; Peverali FA; Della Valle G
Leukemia; 1990 Jun; 4(6):426-30. PubMed ID: 2359342
[TBL] [Abstract][Full Text] [Related]
15. c-kit mRNA expression in human and murine hematopoietic cell lines.
André C; d'Auriol L; Lacombe C; Gisselbrecht S; Galibert F
Oncogene; 1989 Aug; 4(8):1047-9. PubMed ID: 2474787
[TBL] [Abstract][Full Text] [Related]
16. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
17. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells.
Kanakura Y; Ikeda H; Kitayama H; Sugahara H; Furitsu T
Leuk Lymphoma; 1993 May; 10(1-2):35-41. PubMed ID: 7690631
[TBL] [Abstract][Full Text] [Related]
18. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.
Brach MA; Gauer E; Ludwig WD; Ganser A; Mertelsmann R; Herrmann F
Int J Cell Cloning; 1991 Jan; 9(1):89-94. PubMed ID: 2010659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]